top of page

Ketamine for the Treatment of Opioid Use Disorder and Depression

About the study

NCT Trial Number

NCT04177706

The drug being studied

Ketamine

noun_Drug_2240951.png
noun_Institution_118530.png

Sponsored by

Medical University of South Carolina
National Institute on Drug Abuse (NIDA)

noun_date_3237048.png

Trial Start Date

Aug-20

noun_capsule_138144.png

About the participants

Age seeking

18 Years to 65 Years

gender

All

noun_Mental Health_2683241.png

Primary condition of volunteers accepted

Depression

noun_square_138133.png

Accepts healthy volunteers?

No

This study explores the use of ketamine nasal spray with buprenorphine to improve treatment outcomes for patients with both opioid addiction and depression.

Eyes Graffiti

Locations

United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425

Contact: Melissa Michel
843-792-1901
michelem@musc.edu

Contact: Jennifer Jones, MD
843-792-5594
jonjen@musc.edu

​

​

​

​

Get in contact

Find a study site convenient for you below, then email yourself the contact details and next steps

bottom of page